Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 41 | 2024 | 2032 | 5.160 |
Why?
|
Coronary Artery Disease | 36 | 2025 | 6568 | 4.810 |
Why?
|
Acute Coronary Syndrome | 24 | 2024 | 2194 | 4.760 |
Why?
|
Heart Valve Prosthesis Implantation | 28 | 2024 | 1566 | 4.400 |
Why?
|
Drug-Eluting Stents | 10 | 2024 | 681 | 4.230 |
Why?
|
Hospital Mortality | 35 | 2024 | 5349 | 2.800 |
Why?
|
Platelet Aggregation Inhibitors | 20 | 2024 | 2763 | 2.780 |
Why?
|
Aortic Valve | 35 | 2024 | 1970 | 2.540 |
Why?
|
Treatment Outcome | 126 | 2024 | 65379 | 2.380 |
Why?
|
Atrial Fibrillation | 18 | 2024 | 5176 | 2.350 |
Why?
|
Shock, Cardiogenic | 10 | 2024 | 711 | 2.320 |
Why?
|
Endovascular Procedures | 12 | 2024 | 2217 | 2.290 |
Why?
|
Ultrasonography, Interventional | 11 | 2024 | 1524 | 2.280 |
Why?
|
Fibrinolytic Agents | 10 | 2023 | 2080 | 2.250 |
Why?
|
Coronary Artery Bypass | 11 | 2023 | 2191 | 2.240 |
Why?
|
Thrombosis | 9 | 2023 | 2957 | 2.190 |
Why?
|
Heart-Assist Devices | 12 | 2024 | 1292 | 2.030 |
Why?
|
Ventricular Dysfunction, Left | 9 | 2023 | 2145 | 2.000 |
Why?
|
Coronary Angiography | 23 | 2024 | 4541 | 1.970 |
Why?
|
Randomized Controlled Trials as Topic | 41 | 2025 | 10397 | 1.940 |
Why?
|
Acute Kidney Injury | 9 | 2024 | 1942 | 1.870 |
Why?
|
Heart Valve Prosthesis | 13 | 2023 | 1468 | 1.870 |
Why?
|
Heart Failure | 24 | 2024 | 11879 | 1.830 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2024 | 362 | 1.820 |
Why?
|
Myocardial Infarction | 16 | 2024 | 11519 | 1.800 |
Why?
|
Hemorrhage | 22 | 2024 | 3466 | 1.620 |
Why?
|
Renal Dialysis | 7 | 2022 | 1791 | 1.610 |
Why?
|
Anticoagulants | 13 | 2023 | 4850 | 1.600 |
Why?
|
Mitral Valve Insufficiency | 10 | 2024 | 1415 | 1.590 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2023 | 1483 | 1.500 |
Why?
|
Humans | 288 | 2025 | 768171 | 1.490 |
Why?
|
Cardiac Valve Annuloplasty | 2 | 2022 | 51 | 1.480 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2023 | 340 | 1.390 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 3 | 2021 | 539 | 1.370 |
Why?
|
Postoperative Complications | 28 | 2024 | 15833 | 1.360 |
Why?
|
Stroke | 21 | 2024 | 9755 | 1.350 |
Why?
|
Pulmonary Embolism | 5 | 2023 | 2599 | 1.320 |
Why?
|
Peripheral Arterial Disease | 9 | 2024 | 1304 | 1.290 |
Why?
|
Purinergic P2Y Receptor Antagonists | 6 | 2024 | 285 | 1.280 |
Why?
|
Risk Factors | 83 | 2024 | 74944 | 1.280 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2020 | 1724 | 1.260 |
Why?
|
New York City | 8 | 2022 | 737 | 1.220 |
Why?
|
Coronary Occlusion | 3 | 2024 | 306 | 1.200 |
Why?
|
Saphenous Vein | 2 | 2021 | 519 | 1.200 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1605 | 1.190 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2023 | 997 | 1.170 |
Why?
|
Radial Artery | 5 | 2024 | 188 | 1.170 |
Why?
|
Femoral Artery | 7 | 2024 | 829 | 1.140 |
Why?
|
Registries | 15 | 2024 | 8375 | 1.140 |
Why?
|
Stroke Volume | 14 | 2023 | 5622 | 1.080 |
Why?
|
Intra-Aortic Balloon Pumping | 4 | 2024 | 223 | 1.080 |
Why?
|
Alanine | 4 | 2023 | 614 | 1.070 |
Why?
|
Thrombolytic Therapy | 5 | 2023 | 2055 | 1.060 |
Why?
|
Hemoglobins | 3 | 2021 | 1531 | 1.040 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2024 | 2298 | 1.030 |
Why?
|
Patient Readmission | 15 | 2024 | 3288 | 1.010 |
Why?
|
Fractional Flow Reserve, Myocardial | 4 | 2024 | 346 | 1.000 |
Why?
|
Retrospective Studies | 67 | 2024 | 81760 | 0.990 |
Why?
|
Adenosine Monophosphate | 3 | 2021 | 232 | 0.970 |
Why?
|
Coronary Vessel Anomalies | 3 | 2024 | 308 | 0.960 |
Why?
|
Bioprosthesis | 4 | 2023 | 593 | 0.950 |
Why?
|
Coronavirus Infections | 6 | 2021 | 3115 | 0.930 |
Why?
|
Steroids | 4 | 2021 | 938 | 0.920 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2024 | 87 | 0.900 |
Why?
|
Coronary Vessels | 7 | 2024 | 3124 | 0.900 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2021 | 1515 | 0.890 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2024 | 707 | 0.890 |
Why?
|
Tricuspid Valve | 2 | 2024 | 419 | 0.880 |
Why?
|
Blood Vessel Prosthesis Implantation | 5 | 2024 | 1459 | 0.840 |
Why?
|
Japan | 12 | 2023 | 1418 | 0.840 |
Why?
|
Heart Diseases | 4 | 2020 | 2819 | 0.820 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1886 | 0.810 |
Why?
|
Risk Assessment | 33 | 2024 | 24318 | 0.800 |
Why?
|
Aged | 71 | 2024 | 171502 | 0.800 |
Why?
|
Catheterization, Peripheral | 2 | 2024 | 347 | 0.800 |
Why?
|
Blood Transfusion | 3 | 2024 | 1309 | 0.780 |
Why?
|
Aortic Aneurysm, Abdominal | 7 | 2024 | 1250 | 0.770 |
Why?
|
Mitral Valve Annuloplasty | 2 | 2024 | 145 | 0.770 |
Why?
|
Catheter Ablation | 4 | 2024 | 2780 | 0.760 |
Why?
|
Nose Diseases | 1 | 2022 | 78 | 0.760 |
Why?
|
Medicare | 7 | 2024 | 6809 | 0.750 |
Why?
|
Myocardial Revascularization | 6 | 2025 | 795 | 0.740 |
Why?
|
Heart Transplantation | 10 | 2023 | 3301 | 0.740 |
Why?
|
Mucormycosis | 1 | 2022 | 102 | 0.730 |
Why?
|
Coronary Restenosis | 1 | 2023 | 396 | 0.730 |
Why?
|
Time Factors | 29 | 2024 | 40220 | 0.720 |
Why?
|
Coronary Aneurysm | 1 | 2023 | 234 | 0.720 |
Why?
|
Ischemic Attack, Transient | 2 | 2023 | 877 | 0.720 |
Why?
|
Male | 94 | 2024 | 364731 | 0.720 |
Why?
|
Venous Thromboembolism | 3 | 2023 | 1882 | 0.710 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3238 | 0.700 |
Why?
|
Aortic Rupture | 2 | 2020 | 322 | 0.690 |
Why?
|
Antimetabolites | 1 | 2020 | 128 | 0.680 |
Why?
|
Ablation Techniques | 1 | 2023 | 255 | 0.680 |
Why?
|
Orbital Diseases | 1 | 2022 | 178 | 0.680 |
Why?
|
Aged, 80 and over | 37 | 2024 | 59626 | 0.680 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5891 | 0.670 |
Why?
|
Troponin | 2 | 2020 | 535 | 0.670 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2021 | 1065 | 0.660 |
Why?
|
Female | 91 | 2024 | 397187 | 0.660 |
Why?
|
Troponin I | 2 | 2020 | 662 | 0.650 |
Why?
|
Pharmacy | 1 | 2021 | 92 | 0.640 |
Why?
|
Glucosides | 1 | 2024 | 533 | 0.640 |
Why?
|
Vitamin K | 4 | 2023 | 314 | 0.630 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2957 | 0.620 |
Why?
|
Stents | 8 | 2024 | 3197 | 0.620 |
Why?
|
Vascular Diseases | 2 | 2024 | 1162 | 0.610 |
Why?
|
Hospitalization | 12 | 2024 | 10840 | 0.610 |
Why?
|
Coated Materials, Biocompatible | 1 | 2020 | 311 | 0.600 |
Why?
|
Inferior Wall Myocardial Infarction | 1 | 2017 | 10 | 0.590 |
Why?
|
Heart Arrest | 3 | 2023 | 1515 | 0.590 |
Why?
|
Embolism | 1 | 2021 | 401 | 0.590 |
Why?
|
Middle Aged | 55 | 2024 | 223487 | 0.580 |
Why?
|
Endarterectomy, Carotid | 1 | 2023 | 556 | 0.580 |
Why?
|
Drug Therapy, Combination | 4 | 2023 | 6316 | 0.570 |
Why?
|
Mitral Valve | 9 | 2024 | 1475 | 0.560 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 428 | 0.560 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 944 | 0.550 |
Why?
|
Lower Extremity | 3 | 2023 | 1217 | 0.550 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 879 | 0.540 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2023 | 3251 | 0.530 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2022 | 1751 | 0.520 |
Why?
|
Carotid Stenosis | 1 | 2023 | 859 | 0.510 |
Why?
|
Myocarditis | 1 | 2023 | 802 | 0.510 |
Why?
|
Chest Pain | 3 | 2024 | 1101 | 0.510 |
Why?
|
Cardiac Surgical Procedures | 4 | 2024 | 3684 | 0.500 |
Why?
|
Tachycardia, Ventricular | 1 | 2024 | 1309 | 0.490 |
Why?
|
Anemia | 2 | 2024 | 1514 | 0.480 |
Why?
|
Antiviral Agents | 4 | 2023 | 3072 | 0.480 |
Why?
|
Pulmonary Veins | 1 | 2021 | 758 | 0.480 |
Why?
|
Vaccines | 1 | 2023 | 843 | 0.480 |
Why?
|
Administration, Oral | 6 | 2023 | 4034 | 0.470 |
Why?
|
Contrast Media | 4 | 2023 | 5330 | 0.470 |
Why?
|
Dyslipidemias | 1 | 2021 | 873 | 0.460 |
Why?
|
Cardiomyopathies | 2 | 2024 | 2057 | 0.460 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 849 | 0.450 |
Why?
|
Patient Admission | 1 | 2021 | 1365 | 0.440 |
Why?
|
Predictive Value of Tests | 11 | 2024 | 15453 | 0.440 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1334 | 0.440 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 527 | 0.430 |
Why?
|
Behcet Syndrome | 1 | 2014 | 86 | 0.430 |
Why?
|
Mortality | 4 | 2020 | 2911 | 0.420 |
Why?
|
Electrocardiography | 4 | 2022 | 6412 | 0.420 |
Why?
|
Paclitaxel | 1 | 2020 | 1733 | 0.410 |
Why?
|
Aspirin | 3 | 2023 | 3135 | 0.410 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2726 | 0.410 |
Why?
|
Hypercholesterolemia | 3 | 2024 | 1145 | 0.410 |
Why?
|
Incidence | 17 | 2024 | 21538 | 0.400 |
Why?
|
Cardiac Pacing, Artificial | 3 | 2024 | 881 | 0.380 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2138 | 0.370 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1003 | 0.370 |
Why?
|
Pacemaker, Artificial | 4 | 2024 | 828 | 0.370 |
Why?
|
Aortic Aneurysm | 3 | 2020 | 649 | 0.360 |
Why?
|
Prosthesis Design | 6 | 2024 | 2125 | 0.360 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12252 | 0.350 |
Why?
|
Interleukin-6 | 1 | 2020 | 3229 | 0.350 |
Why?
|
Intracranial Embolism | 2 | 2021 | 188 | 0.340 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3214 | 0.340 |
Why?
|
Influenza, Human | 1 | 2020 | 1541 | 0.320 |
Why?
|
Vascular Patency | 2 | 2023 | 917 | 0.320 |
Why?
|
Brain Ischemia | 1 | 2022 | 3007 | 0.310 |
Why?
|
Arrhythmias, Cardiac | 3 | 2024 | 2258 | 0.310 |
Why?
|
United States | 20 | 2024 | 73039 | 0.310 |
Why?
|
Thrombectomy | 3 | 2022 | 675 | 0.300 |
Why?
|
Prosthesis Implantation | 2 | 2024 | 594 | 0.300 |
Why?
|
Atrial Appendage | 2 | 2022 | 285 | 0.300 |
Why?
|
Hospitals | 6 | 2023 | 3886 | 0.290 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1030 | 0.290 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2496 | 0.280 |
Why?
|
Logistic Models | 5 | 2023 | 13290 | 0.280 |
Why?
|
Aortic Valve Insufficiency | 2 | 2022 | 577 | 0.270 |
Why?
|
Databases, Factual | 5 | 2024 | 8080 | 0.270 |
Why?
|
Vaccination | 3 | 2023 | 3437 | 0.270 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2022 | 621 | 0.270 |
Why?
|
Length of Stay | 8 | 2023 | 6498 | 0.260 |
Why?
|
Blood Coagulation | 2 | 2023 | 1162 | 0.260 |
Why?
|
Dementia | 1 | 2021 | 2740 | 0.260 |
Why?
|
Tissue Plasminogen Activator | 2 | 2022 | 1165 | 0.250 |
Why?
|
Lung | 2 | 2022 | 10101 | 0.250 |
Why?
|
Ventricular Function, Left | 6 | 2023 | 3941 | 0.250 |
Why?
|
Biphenyl Compounds | 2 | 2021 | 1026 | 0.250 |
Why?
|
Palliative Care | 1 | 2020 | 3643 | 0.240 |
Why?
|
Follow-Up Studies | 10 | 2022 | 39354 | 0.240 |
Why?
|
Sternotomy | 2 | 2022 | 132 | 0.230 |
Why?
|
Cardiomyopathy, Restrictive | 2 | 2022 | 61 | 0.230 |
Why?
|
Pandemics | 6 | 2022 | 8747 | 0.230 |
Why?
|
Prognosis | 11 | 2024 | 30009 | 0.230 |
Why?
|
Plaque, Atherosclerotic | 3 | 2024 | 1551 | 0.220 |
Why?
|
Comorbidity | 8 | 2024 | 10590 | 0.220 |
Why?
|
Prospective Studies | 11 | 2023 | 54924 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20762 | 0.220 |
Why?
|
Adult | 29 | 2024 | 223646 | 0.220 |
Why?
|
Echocardiography | 3 | 2023 | 5047 | 0.220 |
Why?
|
Limb Salvage | 2 | 2023 | 489 | 0.210 |
Why?
|
Severity of Illness Index | 11 | 2024 | 15949 | 0.210 |
Why?
|
Age Factors | 8 | 2024 | 18415 | 0.210 |
Why?
|
Empyema, Pleural | 1 | 2023 | 62 | 0.210 |
Why?
|
Fee-for-Service Plans | 2 | 2024 | 713 | 0.200 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7454 | 0.200 |
Why?
|
Endarterectomy | 1 | 2023 | 196 | 0.200 |
Why?
|
Famotidine | 1 | 2021 | 17 | 0.190 |
Why?
|
Heart Septum | 1 | 2023 | 304 | 0.190 |
Why?
|
Bacillus | 1 | 2022 | 77 | 0.190 |
Why?
|
Weather | 2 | 2020 | 234 | 0.190 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 43 | 0.190 |
Why?
|
Feasibility Studies | 2 | 2024 | 5315 | 0.190 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2021 | 18 | 0.190 |
Why?
|
Bradycardia | 1 | 2023 | 305 | 0.190 |
Why?
|
Natriuretic Peptides | 1 | 2022 | 156 | 0.190 |
Why?
|
Hypothermia | 1 | 2022 | 189 | 0.180 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2021 | 93 | 0.180 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2022 | 122 | 0.180 |
Why?
|
Neoplasms | 4 | 2023 | 22371 | 0.180 |
Why?
|
Administration, Inhalation | 2 | 2021 | 1169 | 0.180 |
Why?
|
Conjunctivitis, Viral | 1 | 2020 | 6 | 0.180 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1112 | 0.180 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 15662 | 0.180 |
Why?
|
Marfan Syndrome | 1 | 2022 | 237 | 0.180 |
Why?
|
Perindopril | 1 | 2020 | 13 | 0.180 |
Why?
|
Odds Ratio | 3 | 2021 | 9669 | 0.170 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2022 | 238 | 0.170 |
Why?
|
Pleural Effusion | 1 | 2023 | 344 | 0.170 |
Why?
|
Wind | 1 | 2019 | 44 | 0.170 |
Why?
|
Hypothermia, Induced | 2 | 2022 | 754 | 0.170 |
Why?
|
Survival Rate | 7 | 2024 | 12840 | 0.170 |
Why?
|
Cause of Death | 5 | 2021 | 3721 | 0.170 |
Why?
|
Prosthesis Failure | 2 | 2023 | 1208 | 0.160 |
Why?
|
Hospitals, Community | 1 | 2022 | 365 | 0.160 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.160 |
Why?
|
Obesity | 1 | 2021 | 13091 | 0.160 |
Why?
|
Disease Progression | 4 | 2022 | 13668 | 0.160 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12077 | 0.160 |
Why?
|
Propensity Score | 6 | 2022 | 1969 | 0.160 |
Why?
|
Recreation | 1 | 2019 | 124 | 0.160 |
Why?
|
Albuterol | 1 | 2020 | 211 | 0.160 |
Why?
|
Postoperative Hemorrhage | 2 | 2019 | 419 | 0.160 |
Why?
|
Risk | 2 | 2022 | 9613 | 0.160 |
Why?
|
Propofol | 1 | 2024 | 608 | 0.160 |
Why?
|
Immunization, Passive | 1 | 2021 | 619 | 0.160 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 345 | 0.160 |
Why?
|
Carotid Arteries | 1 | 2023 | 942 | 0.160 |
Why?
|
Renin-Angiotensin System | 2 | 2021 | 737 | 0.150 |
Why?
|
Eggs | 1 | 2020 | 182 | 0.150 |
Why?
|
Benzodiazepines | 1 | 2024 | 1138 | 0.150 |
Why?
|
Advance Directives | 1 | 2020 | 249 | 0.150 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2020 | 216 | 0.150 |
Why?
|
Vasodilator Agents | 1 | 2023 | 990 | 0.150 |
Why?
|
Critical Illness | 2 | 2021 | 2755 | 0.150 |
Why?
|
Tissue and Organ Harvesting | 1 | 2021 | 373 | 0.150 |
Why?
|
Recurrence | 3 | 2024 | 8509 | 0.150 |
Why?
|
Surgical Instruments | 1 | 2020 | 381 | 0.150 |
Why?
|
Peptide Fragments | 2 | 2022 | 5151 | 0.150 |
Why?
|
Policy | 1 | 2022 | 513 | 0.150 |
Why?
|
Marriage | 1 | 2019 | 351 | 0.150 |
Why?
|
Titanium | 1 | 2020 | 495 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2024 | 3433 | 0.150 |
Why?
|
Gadolinium | 1 | 2023 | 964 | 0.150 |
Why?
|
Area Under Curve | 1 | 2022 | 1643 | 0.140 |
Why?
|
Anesthesia, General | 1 | 2024 | 1189 | 0.140 |
Why?
|
Mycoses | 1 | 2020 | 386 | 0.140 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1508 | 0.140 |
Why?
|
Coronary Vasospasm | 1 | 2017 | 81 | 0.140 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 393 | 0.140 |
Why?
|
Catheters | 2 | 2017 | 427 | 0.140 |
Why?
|
Adolescent | 8 | 2024 | 89169 | 0.140 |
Why?
|
Popliteal Artery | 1 | 2019 | 313 | 0.140 |
Why?
|
Mitral Valve Stenosis | 1 | 2019 | 342 | 0.140 |
Why?
|
Tachycardia, Supraventricular | 1 | 2019 | 273 | 0.140 |
Why?
|
Drug Combinations | 2 | 2021 | 2089 | 0.140 |
Why?
|
Sex Factors | 4 | 2024 | 10632 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2021 | 599 | 0.140 |
Why?
|
Heart Ventricles | 2 | 2020 | 3841 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1188 | 0.140 |
Why?
|
Hypnotics and Sedatives | 1 | 2024 | 1191 | 0.140 |
Why?
|
Extremities | 1 | 2022 | 870 | 0.140 |
Why?
|
Recovery of Function | 2 | 2024 | 2981 | 0.140 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 489 | 0.140 |
Why?
|
Pericarditis | 1 | 2018 | 136 | 0.130 |
Why?
|
Television | 1 | 2019 | 410 | 0.130 |
Why?
|
Ethanol | 1 | 2023 | 1331 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2022 | 809 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2022 | 535 | 0.130 |
Why?
|
Spironolactone | 1 | 2020 | 415 | 0.130 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1695 | 0.130 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 560 | 0.130 |
Why?
|
Aromatase Inhibitors | 1 | 2020 | 519 | 0.130 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2021 | 454 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2022 | 802 | 0.130 |
Why?
|
Geriatric Assessment | 1 | 2023 | 1422 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2021 | 812 | 0.130 |
Why?
|
Cold Temperature | 1 | 2019 | 791 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2023 | 975 | 0.130 |
Why?
|
Prevalence | 9 | 2024 | 15869 | 0.130 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4262 | 0.120 |
Why?
|
Body Mass Index | 4 | 2022 | 13053 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 837 | 0.120 |
Why?
|
Comprehension | 1 | 2021 | 638 | 0.120 |
Why?
|
Bacteremia | 1 | 2022 | 985 | 0.120 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1103 | 0.120 |
Why?
|
Hemodynamics | 3 | 2020 | 4194 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1410 | 0.120 |
Why?
|
Child | 5 | 2023 | 80917 | 0.120 |
Why?
|
Lactic Acid | 1 | 2020 | 1140 | 0.120 |
Why?
|
Benzimidazoles | 1 | 2020 | 864 | 0.120 |
Why?
|
Robotics | 1 | 2021 | 812 | 0.120 |
Why?
|
Gait | 1 | 2020 | 823 | 0.120 |
Why?
|
Amyloidosis | 1 | 2022 | 877 | 0.110 |
Why?
|
Patient Discharge | 3 | 2022 | 3479 | 0.110 |
Why?
|
Tetrazoles | 1 | 2020 | 923 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 1004 | 0.110 |
Why?
|
Hot Temperature | 1 | 2020 | 1440 | 0.110 |
Why?
|
Heart Atria | 2 | 2023 | 1361 | 0.110 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12543 | 0.110 |
Why?
|
Anticholesteremic Agents | 1 | 2021 | 972 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2021 | 1032 | 0.110 |
Why?
|
Fontan Procedure | 1 | 2019 | 805 | 0.110 |
Why?
|
Arterio-Arterial Fistula | 1 | 2013 | 21 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2029 | 0.110 |
Why?
|
Sulfonamides | 1 | 2023 | 1982 | 0.100 |
Why?
|
Calcium | 2 | 2023 | 5792 | 0.100 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1399 | 0.100 |
Why?
|
Creatinine | 1 | 2018 | 1918 | 0.100 |
Why?
|
Azathioprine | 1 | 2014 | 354 | 0.100 |
Why?
|
Bone Density Conservation Agents | 1 | 2020 | 797 | 0.100 |
Why?
|
Forecasting | 1 | 2022 | 2945 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 1485 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1397 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2022 | 2167 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4861 | 0.100 |
Why?
|
Coronary Thrombosis | 1 | 2015 | 440 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1179 | 0.100 |
Why?
|
Glucose | 1 | 2024 | 4352 | 0.100 |
Why?
|
Cohort Studies | 5 | 2024 | 41753 | 0.100 |
Why?
|
Social Class | 1 | 2020 | 2008 | 0.090 |
Why?
|
Endoscopy | 1 | 2021 | 1854 | 0.090 |
Why?
|
Hepatitis C | 1 | 2021 | 1595 | 0.090 |
Why?
|
Young Adult | 6 | 2024 | 60066 | 0.090 |
Why?
|
Survival Analysis | 2 | 2020 | 10099 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3728 | 0.090 |
Why?
|
Osteoporosis | 1 | 2020 | 1605 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2020 | 3205 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2227 | 0.090 |
Why?
|
Immunosuppressive Agents | 3 | 2022 | 4206 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2019 | 1271 | 0.080 |
Why?
|
Pulmonary Artery | 2 | 2022 | 1946 | 0.080 |
Why?
|
Heart | 1 | 2022 | 4446 | 0.080 |
Why?
|
Prednisone | 1 | 2014 | 1567 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9384 | 0.080 |
Why?
|
Parents | 1 | 2023 | 3595 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2523 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1885 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4530 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2566 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1960 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2020 | 2401 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3858 | 0.070 |
Why?
|
Tissue Donors | 3 | 2022 | 2381 | 0.070 |
Why?
|
Reoperation | 3 | 2024 | 4329 | 0.070 |
Why?
|
Inflammation | 2 | 2020 | 10873 | 0.070 |
Why?
|
Graft Rejection | 4 | 2022 | 4492 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2023 | 12801 | 0.070 |
Why?
|
Cities | 2 | 2020 | 543 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.070 |
Why?
|
Models, Statistical | 1 | 2022 | 5107 | 0.070 |
Why?
|
Bone Density | 1 | 2020 | 3573 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5520 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5099 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7852 | 0.070 |
Why?
|
Heart Defects, Congenital | 2 | 2020 | 4712 | 0.060 |
Why?
|
Temperature | 2 | 2022 | 2234 | 0.060 |
Why?
|
Research Design | 1 | 2022 | 6209 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3252 | 0.060 |
Why?
|
Sepsis | 1 | 2020 | 2608 | 0.060 |
Why?
|
Kidney | 1 | 2021 | 7064 | 0.060 |
Why?
|
Child, Preschool | 3 | 2023 | 42669 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3415 | 0.060 |
Why?
|
Angiography | 2 | 2024 | 1597 | 0.060 |
Why?
|
Postoperative Period | 2 | 2020 | 1826 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4746 | 0.060 |
Why?
|
Ischemia | 2 | 2023 | 1900 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1401 | 0.050 |
Why?
|
Mineral Oil | 1 | 2022 | 21 | 0.050 |
Why?
|
Corn Oil | 1 | 2022 | 29 | 0.050 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 82 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4887 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5432 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2023 | 324 | 0.050 |
Why?
|
Endoleak | 1 | 2022 | 111 | 0.050 |
Why?
|
Deoxyribonucleases | 1 | 2023 | 209 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6291 | 0.050 |
Why?
|
Anesthetics, Intravenous | 1 | 2024 | 397 | 0.050 |
Why?
|
Equipment Design | 2 | 2024 | 3522 | 0.050 |
Why?
|
Aorta, Abdominal | 1 | 2024 | 627 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4790 | 0.050 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2021 | 144 | 0.050 |
Why?
|
Graft Survival | 2 | 2022 | 3887 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 389 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 30255 | 0.050 |
Why?
|
Ramipril | 1 | 2021 | 102 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 6004 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6340 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13677 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2023 | 305 | 0.040 |
Why?
|
Gram-Negative Bacteria | 1 | 2022 | 275 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1104 | 0.040 |
Why?
|
Heart-Lung Transplantation | 1 | 2020 | 87 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7243 | 0.040 |
Why?
|
Thoracotomy | 1 | 2021 | 374 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2021 | 492 | 0.040 |
Why?
|
Enalapril | 1 | 2021 | 317 | 0.040 |
Why?
|
Septal Occluder Device | 1 | 2020 | 126 | 0.040 |
Why?
|
Coma | 1 | 2022 | 485 | 0.040 |
Why?
|
Debridement | 1 | 2021 | 494 | 0.040 |
Why?
|
Hypotension | 1 | 2024 | 888 | 0.040 |
Why?
|
Perioperative Period | 1 | 2020 | 253 | 0.040 |
Why?
|
Brain Death | 1 | 2022 | 359 | 0.040 |
Why?
|
Waiting Lists | 1 | 2023 | 779 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 565 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Neprilysin | 1 | 2021 | 487 | 0.040 |
Why?
|
Physicians, Women | 1 | 2024 | 517 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1401 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1127 | 0.040 |
Why?
|
No-Reflow Phenomenon | 1 | 2017 | 16 | 0.040 |
Why?
|
Cattle | 1 | 2023 | 3819 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1820 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1014 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2023 | 1277 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13586 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 590 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 1831 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2023 | 939 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16726 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 914 | 0.030 |
Why?
|
Fever | 1 | 2022 | 1614 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1540 | 0.030 |
Why?
|
Hospital Costs | 1 | 2021 | 957 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1667 | 0.030 |
Why?
|
Protein Precursors | 1 | 2018 | 1135 | 0.030 |
Why?
|
Hepacivirus | 1 | 2021 | 1344 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2020 | 937 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1813 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 2403 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 843 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1126 | 0.030 |
Why?
|
Abdomen | 1 | 2020 | 1136 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2204 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7477 | 0.030 |
Why?
|
Delirium | 1 | 2024 | 1696 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21207 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2725 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1282 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4834 | 0.030 |
Why?
|
Collateral Circulation | 1 | 2013 | 291 | 0.020 |
Why?
|
Income | 1 | 2020 | 1878 | 0.020 |
Why?
|
Liver Diseases | 1 | 2020 | 1305 | 0.020 |
Why?
|
Perioperative Care | 1 | 2019 | 1043 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2649 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4149 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13490 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13013 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36741 | 0.020 |
Why?
|
Lung Diseases | 1 | 2020 | 1944 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3445 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2020 | 2100 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10763 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2013 | 893 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36535 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2013 | 1617 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8052 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14783 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 13045 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 1091 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20225 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9419 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6986 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22290 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11878 | 0.010 |
Why?
|
Animals | 1 | 2023 | 169285 | 0.010 |
Why?
|